Greg Bonello

498 total citations
13 papers, 214 citations indexed

About

Greg Bonello is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Greg Bonello has authored 13 papers receiving a total of 214 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Greg Bonello's work include CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (6 papers) and CRISPR and Genetic Engineering (5 papers). Greg Bonello is often cited by papers focused on CAR-T cell therapy research (13 papers), Immune Cell Function and Interaction (6 papers) and CRISPR and Genetic Engineering (5 papers). Greg Bonello collaborates with scholars based in United States, Sweden and Norway. Greg Bonello's co-authors include Ryan Bjordahl, Svetlana Gaidarova, Bahram Valamehr, Sajid Mahmood, Jeffrey S. Miller, Frank Cichocki, Bruce Walcheck, Brian Groff, Jode Goodridge and Tom Lee and has published in prestigious journals such as Blood and Cancer Research.

In The Last Decade

Greg Bonello

13 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg Bonello United States 6 181 152 63 33 14 13 214
Licui Jiang China 6 182 1.0× 150 1.0× 37 0.6× 34 1.0× 17 1.2× 8 212
Jode Goodridge United States 8 240 1.3× 187 1.2× 83 1.3× 42 1.3× 28 2.0× 20 285
Lorena Pérez-Amill Spain 7 150 0.8× 131 0.9× 41 0.7× 20 0.6× 33 2.4× 11 200
Faustine Lhomme France 9 117 0.6× 96 0.6× 50 0.8× 27 0.8× 15 1.1× 13 201
Alexis Cuffel France 6 105 0.6× 60 0.4× 45 0.7× 20 0.6× 6 0.4× 7 140
Luciana Melo Garcia Canada 4 97 0.5× 84 0.6× 34 0.5× 13 0.4× 17 1.2× 7 124
Katherine A. Freitas United States 2 179 1.0× 116 0.8× 140 2.2× 34 1.0× 15 1.1× 4 267
Austin K. Rennels United States 4 156 0.9× 55 0.4× 80 1.3× 57 1.7× 12 0.9× 4 191
Amod Sarnaik United States 5 190 1.0× 295 1.9× 103 1.6× 17 0.5× 9 0.6× 17 360
Cheryl McAlpine United States 6 145 0.8× 154 1.0× 73 1.2× 24 0.7× 12 0.9× 12 254

Countries citing papers authored by Greg Bonello

Since Specialization
Citations

This map shows the geographic impact of Greg Bonello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Bonello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Bonello more than expected).

Fields of papers citing papers by Greg Bonello

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Bonello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Bonello. The network helps show where Greg Bonello may publish in the future.

Co-authorship network of co-authors of Greg Bonello

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Bonello. A scholar is included among the top collaborators of Greg Bonello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Bonello. Greg Bonello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Cichocki, Frank, Ryan Bjordahl, Sajid Mahmood, et al.. (2022). Dual antigen–targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia. Blood. 140(23). 2451–2462. 58 indexed citations
2.
Mbofung, Rina M., Yijia Pan, Brian Groff, et al.. (2021). Off-the-Shelf, iPSC-Derived CAR-NK Cells Multiplexed-Engineered for the Avoidance of Allogeneic Host Immune Cell Rejection. Blood. 138(Supplement 1). 2795–2795. 2 indexed citations
3.
Goodridge, Jode, Ryan Bjordahl, Sajid Mahmood, et al.. (2021). Abstract 1550: FT576 path to first-of-kind clinical trial: translation of a versatile multi-antigen specific off-the-shelf NK cell for treatment of multiple myeloma. Cancer Research. 81(13_Supplement). 1550–1550. 7 indexed citations
6.
Bjordahl, Ryan, Zhu Huang, Paul Rogers, et al.. (2019). Abstract 3191: FT516, an off-the-shelf engineered NK cell therapeutic product for universal anti-tumor targeting strategy in combination with monoclonal antibodies. Cancer Research. 79(13_Supplement). 3191–3191. 1 indexed citations
7.
Goodridge, Jode, Sajid Mahmood, Zhu Huang, et al.. (2019). FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the-Shelf CAR-NK Cell with Engineered Persistence for the Treatment of B Cell Malignancies. Blood. 134(Supplement_1). 301–301. 66 indexed citations
8.
Goodridge, Jode, Sajid Mahmood, Zhu Huang, et al.. (2019). Abstract 3207: Preclinical development of first-of-kind dual-targeted off-the-shelf CAR-NK cell product with engineered persistence for an effective treatment of B cell malignancies. Cancer Research. 79(13_Supplement). 3207–3207. 1 indexed citations
10.
Bjordahl, Ryan, Svetlana Gaidarova, Jode Goodridge, et al.. (2019). FT576: A Novel Multiplexed Engineered Off-the-Shelf Natural Killer Cell Immunotherapy for the Dual-Targeting of CD38 and Bcma for the Treatment of Multiple Myeloma. Blood. 134(Supplement_1). 3214–3214. 26 indexed citations
12.
Bjordahl, Ryan, Raedun Clarke, Svetlana Gaidarova, et al.. (2017). Multi-Functional Genetic Engineering of Pluripotent Cell Lines for Universal Off-the-Shelf Natural Killer Cell Cancer Immunotherapy. Blood. 130. 3187–3187. 1 indexed citations
13.
Clarke, Raedun, Brian Groff, Tom Tong Lee, et al.. (2016). Genetically Enhanced Pluripotent Stem Cell-Derived T Lymphocytes for Off-the-Shelf Cellular Immunotherapy. Blood. 128(22). 2164–2164. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026